Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Hagan

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
British Journal of Pharmacology|May 12, 2000
[(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptorsD R Thomas, P J Atkinson, M Ho, et al.
Psychopharmacology|July 10, 2001
Central effects of urotensin-II following ICV administration in ratsJ Gartlon, F Parker, D C Harrison, et al.
Annals of the New York Academy of Sciences|February 3, 1999
The selective 5-HT1B receptor inverse agonist SB-224289, potently blocks terminal 5-HT autoreceptor function both in vitro and in vivoL M Gaster, P Ham, G F Joiner, et al.
Journal of Medicinal Chemistry|March 26, 1998
(R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: the first selective 5-HT7 receptor antagonistI T Forbes, S Dabbs, D M Duckworth, et al.
Psychopharmacology|February 24, 2001
Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivityD N Jones, J Gartlon, F Parker, et al.
British Journal of Pharmacology|May 24, 2000
Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonistJ J Hagan, G W Price, P Jeffrey, et al.
Journal of Medicinal Chemistry|February 12, 2000
A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970)P J Lovell, S M Bromidge, S Dabbs, et al.
Journal of Medicinal Chemistry|May 10, 1996
Design and synthesis of 2-naphthoate esters as selective dopamine D4 antagonistsI Boyfield, T H Brown, M C Coldwell, et al.
Molecular Psychiatry|March 4, 2009
Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal functionP R Maycox, F Kelly, A Taylor, et al.
Journal of Medicinal Chemistry|May 5, 2000
Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the ratG Stemp, T Ashmeade, C L Branch, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
British Journal of Pharmacology|May 12, 2000
[(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptorsD R Thomas, P J Atkinson, M Ho, et al.
Psychopharmacology|July 10, 2001
Central effects of urotensin-II following ICV administration in ratsJ Gartlon, F Parker, D C Harrison, et al.
Annals of the New York Academy of Sciences|February 3, 1999
The selective 5-HT1B receptor inverse agonist SB-224289, potently blocks terminal 5-HT autoreceptor function both in vitro and in vivoL M Gaster, P Ham, G F Joiner, et al.
Journal of Medicinal Chemistry|March 26, 1998
(R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: the first selective 5-HT7 receptor antagonistI T Forbes, S Dabbs, D M Duckworth, et al.
Psychopharmacology|February 24, 2001
Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivityD N Jones, J Gartlon, F Parker, et al.
British Journal of Pharmacology|May 24, 2000
Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonistJ J Hagan, G W Price, P Jeffrey, et al.
Journal of Medicinal Chemistry|February 12, 2000
A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970)P J Lovell, S M Bromidge, S Dabbs, et al.
Journal of Medicinal Chemistry|May 10, 1996
Design and synthesis of 2-naphthoate esters as selective dopamine D4 antagonistsI Boyfield, T H Brown, M C Coldwell, et al.
Molecular Psychiatry|March 4, 2009
Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal functionP R Maycox, F Kelly, A Taylor, et al.
Journal of Medicinal Chemistry|May 5, 2000
Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the ratG Stemp, T Ashmeade, C L Branch, et al.
Pageof 8